Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Spondylarthritis × Etanercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 9 Spondylarthritis 1 Recurrence 1 Psoriasis 1 Melanoma 1 Autoimmune Diseases 1 Arthritis, Psoriatic 1

Interventions

Tumor Necrosis Factor Inhibitors 1 Etanercept 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02364479 2019-12-19

Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein

Sun Yat-sen University

Phase 4 Completed

Recurrence, Spondylarthritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡